Passage Bio, Inc. (PASG) Tops Q2 EPS by 3c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• Bending Spoons closes IPO, raises ~$954M on Nasdaq